期刊文献+

食管鳞癌中骨桥蛋白的表达及与血管生成关系 被引量:1

Expression of osteopontin and tumor angiogenesis in esophageal squamous cell carcinoma
下载PDF
导出
摘要 目的观察骨桥蛋白(OPN)在食管鳞癌组织中的表达状况,同时观察食管鳞癌组织中血管生成状况,探讨OPN与血管生成的关系。方法运用免疫组化S-P法做44例食管鳞癌组织兔抗人骨桥蛋白抗体染色,用抗CD34单克隆抗体做44例食管鳞癌组织免疫组化染色,并在显微镜下作MVD计数。结果OPN在食管癌组织的表达率为86.3%。癌组织中OPN主要表达于肿瘤细胞的细胞浆中。全组44例标本MVD计数为24.07±5.82,癌巢及癌细胞密集区MVD少于癌周区域。本研究提示,OPN阳性组MVD高于阴性组(P<0.05)。等级相关分析,结果表明OPN表达与MVD呈正相关(r=0.320,P=0.034)。结论食管鳞癌组织中OPN主要由肿瘤细胞产生。食管鳞癌中存在活跃的血管生成。OPN与血管生成关系密切。 Objective To observe the expression of osteopontin(OPN) and the expression of CD34 and count microvessel density in esophageal squamons cell carcinoma, to explore the effect of OPN in tumor anglogenesis. Methods S-P inanunohistochemical staining was used to investigate the expression of OPN by anti-osteopontin polyclonal antibody and the expression of CD34 by anti-CD34 polyclonal antibody in the specimens of 44 cases of esophageal squamons cell carcinoma, and nficrovessel density was counted in the high power field ( × 400) of microscope. Results The total positive rate of OPN expression in 44 cases of esophageal squanaous cell carcinoma is 86.3 %. OPN was mainly distributed in cytoplasm of tumor cells. The microvessel density counting of 44 cases of esophageal squamous cell carcinoma is 24.07±5.82. The microvessel of carcinoma nests was less than the area around it. It was found that the MVD of OPN expression in positive was higher than that in negative. Rank correlated analysis showed that OPN and MVD were positive correlated. Conclusion OPN was mainly produced by tumor cells. There was active angiogenesis in esophageal squanaous cell carcinoma. OPN had close relationship with tumor angiogenesis in esophageal squanaons cell carcinoma.
出处 《实用肿瘤学杂志》 CAS 2007年第5期403-405,共3页 Practical Oncology Journal
关键词 骨桥蛋白 食管癌 鳞状细胞癌 血管生成 免疫组化 Osteopontin Esophageal Carcinoma Squamons cell carcinoma Angiogenesis Inanunohistochemistry
  • 相关文献

参考文献9

  • 1weidner N. Current Pathologic methods of measuring intratumoral mierovessel density within breast carcinoma and other solider tumors[J]. Breast Cancer Res Treat, 1995;36(2) : 169-180
  • 2Goldsmith HL, Labrosse JM, Mclntosh FA, et al. Homotypic interactions of soluble and immobilized osteopontin [J]. Ann Biomed Eng,2002; 30 (6): 840-850
  • 3Casson AG, Wilson SM, McCart JA, et al. Ras mutation and expression of the ras-regulated genes osteopontin and eathepsin L in human esophageal cancer[J].Int J Cancer, 1997;72(5):739-745
  • 4Gillespie MT,Thomas R J, Pu ZY, et al. Calcitonin receptors, bone sialoprotein and osteopontin are expressed in primary breast cancers[J]. Int J Cancer, 1997;73(6) :812-815
  • 5Carmeliet P, et al. Angiogenesis in cancer and other diseases. Nature, 2000;407(6801) :249-257
  • 6Shijnbo N, Uede T, Kon S, et al. Vascular endothelial growth factor and osteopontin in tumor biology[J]. Crit Rev Oncog, 2000 ; 11(2): 135-146
  • 7Hamada Y, Nokihara K, Okazaki M, et al. Angiogenic activity of osteopontin-derived peptide SVVYGLR [J]. Biochem Biophys Res Commun, 2003 ;310(1): 153-157
  • 8Leali D,Dell'Era P,Stabile H,et al.Osteopontin(Eta-1) and fibroblast growth factor-2 cross-talk in angiogenesis[J]. J Immunol,2003; 171(2): 1085-1093
  • 9Hirama M, Takahashi F, Takahashi K,et al. Osteopontin overproduced by tumor cells acts as a potent angiogenic factor contributing to tumor growth [J]. Cancer Lett ,2003 ; 198(1): 107-117

同被引文献19

引证文献1

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部